The use of cheaper generic alternatives that are no longer patent-protected rose to an all-time high in the private sector in 2018, according to the latest Mediscor review.

The trend highlights the continued impact of the health department’s laws encouraging the use of generics, combined with measures taken by medical schemes to discourage the use of more expensive branded products...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.